داروسازی ابوریحان
دابور | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 65,540 2.99
Close Price: 65,560
Cash Flow
AGM
Interim
2026/06/16 Fiscal Year 2026/03/2012 Month / Audited | 2026/06/13 Fiscal Year 2026/03/2012 Month | ||
|---|---|---|---|
Cash Generated from Operations | 6.563 Trillion | 7.181 Trillion | |
Income Taxes Paid | -166.137 Billion | -166.137 Billion | |
Net Cash Flow from Operating Activities | 6.397 Trillion | 7.014 Trillion | |
Purchases of Property, Plant and Equipment | -51.679 Billion | -51.679 Billion | |
Proceeds from Sale of Long-Term Investments | - | 43.978 Billion | |
Cash Paid to Acquire Long-Term Investments | -800 Million | - | |
Dividends Received | 12.303 Billion | 12.303 Billion | |
Cash Received from Income on Other Investments | 2.799 Billion | 2.799 Billion | |
Net Cash Flow from Investing Activities | -37.377 Billion | 7.401 Billion | |
Net Cash Flow before Financing Activities | 6.359 Trillion | 7.022 Trillion | |
Proceeds from Sale of Treasury Shares | 57.754 Billion | 57.754 Billion | |
Purchases of Treasury Shares | -102.532 Billion | -102.532 Billion | |
Cash Received from Borrowings | 5.418 Trillion | 5.418 Trillion | |
Repayments of Borrowings (Principal) | -8.633 Trillion | -9.295 Trillion | |
Interest Paid on Borrowings | -2.433 Trillion | -2.433 Trillion | |
Dividends Paid | -994.797 Billion | -994.797 Billion | |
Net Cash Flow from Financing Activities | -6.688 Trillion | -7.35 Trillion | |
Net Increase (Decrease) in Cash | -328.418 Billion | -328.418 Billion | |
Cash at Beginning of Period | 481.194 Billion | 481.194 Billion | |
Effect of Exchange Rate Changes | 410.726 Billion | 410.726 Billion | |
Cash at End of Period | 891.92 Billion | 891.92 Billion |